289 related articles for article (PubMed ID: 34745328)
21. Critical cholangiocarcinogenesis control by cryptochrome clock genes.
Mteyrek A; Filipski E; Guettier C; Oklejewicz M; van der Horst GT; Okyar A; Lévi F
Int J Cancer; 2017 Jun; 140(11):2473-2483. PubMed ID: 28224616
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of circadian clock genes in head and neck squamous cell carcinoma.
Hsu CM; Lin SF; Lu CT; Lin PM; Yang MY
Tumour Biol; 2012 Feb; 33(1):149-55. PubMed ID: 22081375
[TBL] [Abstract][Full Text] [Related]
23. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics analysis of the prognosis and therapeutic significance of circadian clock in ovarian cancer.
Zhu J; Zhou Q; Pan M; Zhou C
Gene; 2021 Jul; 788():145644. PubMed ID: 33848579
[TBL] [Abstract][Full Text] [Related]
25. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
27. The effect of dexamethasone on clock gene mRNA levels in bovine neutrophils and lymphocytes.
Nebzydoski SJ; Pozzo S; Nemec L; Rankin MK; Gressley TF
Vet Immunol Immunopathol; 2010 Dec; 138(3):183-92. PubMed ID: 20807668
[TBL] [Abstract][Full Text] [Related]
28. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract][Full Text] [Related]
29. Expression of circadian core clock genes in fibroblasts of human gingiva and periodontal ligament is modulated by L-Mimosine and hypoxia in monolayer and spheroid cultures.
Janjić K; Kurzmann C; Moritz A; Agis H
Arch Oral Biol; 2017 Jul; 79():95-99. PubMed ID: 28350992
[TBL] [Abstract][Full Text] [Related]
30. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
31. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
[No Abstract] [Full Text] [Related]
32. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
33. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
34. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma.
Li L; Huang K; Lu Z; Zhao H; Li H; Ye Q; Peng G
Oncol Rep; 2020 Nov; 44(5):2185-2197. PubMed ID: 33000250
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy.
Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T
Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708
[TBL] [Abstract][Full Text] [Related]
37. Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining.
Zhang Y; Wang Y; Liu H; Li B
J Cell Physiol; 2019 Jun; 234(6):9787-9792. PubMed ID: 30556603
[TBL] [Abstract][Full Text] [Related]
38. Research on circadian clock genes in non-small-cell lung carcinoma.
Qiu M; Chen YB; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jun; 36(6):739-750. PubMed ID: 31014124
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
40. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma.
Yu C; Yang SL; Fang X; Jiang JX; Sun CY; Huang T
Mol Med Rep; 2015 May; 11(5):4002-8. PubMed ID: 25591621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
